Chioma S. Ejekam

1

Article

1

Comment

I am a Consultant Public Health physician(FMCPH, MWACP), an IPC Consultant and an expert in Pharmacovigilance and Pharmacoepidemiology. I have a Master’s degree in Pharmacovigilance and Pharmacoepidemiology from Eu2P - Universite de Bordeaux with specialization from Erasmus Medical Center Netherlands; Master’s in Public Health as well as Medicine and Surgery degree from the University of Lagos Nigeria. I have experience and Certificate trainings in Implementation research; Leadership and management in health, and Quality of Medical products and Global Health. I am currently the Co-lead West Africa for International Society of Pharmacoepidemiology Africa Chapter (ISPE-Africa).
I have over 13 years of experience working closely with diverse stakeholders from the community, government institutions, bilateral/multilateral organizations in the field of public health.
I describe myself as a quality improvement (QI) enthusiast as I have a default interest in patient safety, access to safe and quality medical products - (Medicines and global health) and health worker safety, patient safety and quality health services delivery - (Infection prevention and control - IPC).

I am passionate about research especially - HIV/AIDS, pharmacovigilance and Pharmacoepidemiology, maternal health medicines(uterotonics), safe and quality medicines including vaccines and IPC.

Experience

  • 2020–present
    Faculty position , African Centre of Excellence for Drug Research, Herbal Medicine Development and Regulatory Science (ACEDHARS) of the University of Lagos
  • 2020–present
    Faculty, Center for Infection Control and Patient Safety (CiCAPS) – College of Medicine of the University of Lagos.
  • 2020–present
    Member Technical Working Group – Development of the first Nigeria National Vaccine Policy , Bloom Public Health
  • –present
    Training Coordinator South west Zonal Centre for Pharmacovigilance, Lagos University Teaching Hospital, University of Lagos
  • 2020–present
    IPC Consultant - Lead Data and Project Management , Infection Control Africa Network (ICAN)
  • 2017–2021
    Principal Investigator/Consultant - Medicines and public health, U.S Pharmacopeia
  • 2018–2021
    Co-Lead West Africa, International Society of Pharmacoepidemiology (ISPE)

Education

  • 2019 
    Faculty of Public Health and Community medicine, National Postgraduate Medical College of Nigeria, FMCPH – Fellow Medical College of Public Health and Community Medicine
  • 2017 
    Eu2P Consortium-University of Bordeaux and Erasmus Medical Centre Netherlands, M.Sc., Pharmacovigilance and Pharmacoepidemiology
  • 2011 
    University of Lagos Nigeria, MPH – Master of Public Health
  • 2005 
    College of Medicine, University of Lagos, Nigeria, MB,BS – Medicine and Surgery

Publications

  • 2021
    Nigeria National Vaccine Policy – , 1st Edition
  • 2021
    A descriptive study of healthcare-providers' experiences with the use and quality of oxytocin for the prevention of post-partum hemorrhage in Nigeria: A nation-wide survey. , PLoS One. 2021 Oct 6;16(10):e0258096
  • 2021
    From Ebola to COVID-19: emergency preparedness and response plans and actions in Lagos, Nigeria. , Globalization and Health (2021) 17:79
  • 2020
    COVID-19 and risks to the supply and quality of tests, drugs, and vaccines, The Lancet Global Health
  • 2020
    Evaluation of Pharmacovigilance activities in the National HIV/AIDS, Malaria and Tuberculosis control programs using the World Health Organization Pharmacovigilance Indicators., Sahel Med J 2020;23(4):226-35.
  • 2019
    HIV/AIDS-Related knowledge, attitude and uptake of HIV Testing services: A comparative study of male and female secondary school students in Lagos, Nigeria. , West Afr J Med.
  • 2019
    Clinical experiences with the use of oxytocin injection by healthcare providers in a South-Western State Nigeria: A Cross sectional study., PLos One. 2019 Oct 10;14(10);
  • 2019
    Global access to quality-assured medical products: the Oxford Statement and call to action. Long Statement. , Lancet GH 2019;e1609-11.
  • 2019
    Global access to quality-assured medical products: the Oxford Statement and call to action. Long Statement. , Lancet GH 2019;e1609-11.
  • 2016
    Pharmacist-led smoking cessation: The attitudes and practices of Community pharmacists in Lagos state, Nigeria. A mixed methods survey. , Tob. Prev. Cessation
  • 2014
    Adverse Drug Reactions to Antiretroviral drugs at Lagos University Teaching Hospital HIV Clinic, Lagos, South-West Nigeria , West African journal of Pharmacy

Grants and Contracts

  • 2019
    Oxytocin expansion study
    Role:
    Principal Investigator
    Funding Source:
    MSD for Mothers
  • 2018
    Oxytocin pilot study
    Role:
    Principal Investigator
    Funding Source:
    U.S Pharmacopeia

Professional Memberships

  • Infection Control Africa Network
  • Nigeria Society for Infection Control
  • International Society of Pharmacoepidemiology (ISPE)
  • African Society Of Pharmacovigilance (ASOP)
  • Association of Public Health Physicians of Nigeria (APHPN)
  • International AIDS Society (IAS)
  • Medical and Dental Council of Nigeria (MDCN)

Contact Chioma for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision